Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05991115 · ClinicalTrials.gov registry record · NA
Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care
A NA study of Asthma and Asthma in Children, sponsored by Kavita Parikh.
- Recruiting
- Registry status
- NA
- Development phase
- 340
- Enrollment target
- 1
- Study location
NCT05991115: Recruiting NA study of Asthma and Asthma in Children, sponsored by Kavita Parikh.
NCT05991115 is a NA study of Asthma and Asthma in Children that is actively recruiting participants, run by Kavita Parikh. The registered enrollment target is 340 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05991115, a NA study of Asthma and Asthma in Children, is actively recruiting participants, sponsored by Kavita Parikh.
- RECRUITING
- Registry status
- NA
- Development phase
- 340 participants
- Enrollment target
- 1
- Study location
Study Summary
Caregiver-child dyads will be recruited during child's hospital admission for asthma exacerbation. Recruitment sites will be mainly Children's National Hospital Sheikh Zayed campus, as well as regional partners: Holy Cross Hospital, and Mary Washington Hospital. After enrollment, baseline data will be collected from caregiver. Caregiver-child dyads will be randomized (1:1 ratio) into the control arm or intervention arm. Control arm will receive the standard of care after hospital discharge. Intervention arm will receive the SOC plus an asthma navigator support after hospital discharge. Caregivers in both arms will complete data collection surveys (either in-person or via telehealth) at 3-,6-, 9-, and 12- month post enrollment.
Primary Outcome
Asthma-related readmissions over 12-month follow-up period from index hospitalization
Conditions Studied
Interventions
- BEHAVIORAL Hospital to Home Transition (H2H)
Study Locations (1)
District of Columbia
- Children's National Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2024-01-22 |
| Est. Completion | 2027-07 |
| Phase | NA |
What NCT05991115 shows while recruiting
NCT05991115 is an interventional study that assigns participants to a tested intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Hospital to Home Transition (H2H) is the first listed.
NCT05991115 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05991115 about?
NCT05991115 is a clinical study titled "Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care". Caregiver-child dyads will be recruited during child's hospital admission for asthma exacerbation. Recruitment sites will be mainly Children's National Hospital Sheikh Zayed campus, as well as regional partners: Holy Cross Hospital, and Mary Washington Hospital. After enrollment, baseline data will ...
What is the current status of trial NCT05991115?
This trial is currently recruiting. It is a NA study. The enrollment target is 340 participants. The study started on 2024-01-22. Estimated completion is 2027-07.
What conditions does trial NCT05991115 study?
This clinical trial studies the following conditions: Asthma, Asthma in Children.
What interventions are being tested in trial NCT05991115?
The interventions under investigation include: Hospital to Home Transition (H2H) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05991115?
This trial is sponsored by Kavita Parikh, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05991115 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05991115's enrollment target sits among peer trials
340 109th of 374 higher than 266 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT04806958 · 340 participants · NA
The PulsePoint Study
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI